Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1984-09-18
1987-10-13
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
435235, 435238, 435240, 435241, A61K 3921, C12N 700, C12N 706, C12N 500
Patent
active
046997857
ABSTRACT:
A novel feline fibroblastic cell line infected with Snyder-Theilen feline leukemia virus is provided. The cell line produces large amounts of FeLV when cultured in a medium free from serum supplement. The latter aspect is a substantial advantage since it reduces the expense of culturing and eliminates the need to separate serum from culture medium prior to preparing a vaccine.
Feline fibroblastic cell line FF64/280 was deposited at the American Type Culture Collection on Apr. 17, 1984, and granted accession no. VR 2085.
REFERENCES:
patent: 3520972 (1970-07-01), Smith et al.
patent: 4117112 (1978-09-01), Jarrett et al.
patent: 4264587 (1981-04-01), Pedersen et al.
patent: 4303644 (1981-01-01), Davis
patent: 4434157 (1984-02-01), Olsen
Pedersen et al. (1978), Am. J. Vet. Res., 40:1120-1126.
Mathes et al. (1980), by Elsevier/North Holland, Inc., Hardy, Essex and McClelland, eds. Feline Leukemia Virus, vol. No. 4.
Lewis et al. (1981), Infection and Immunity, pp. 888-894.
Hazel Blondel
Rowland Bertram I.
The Regents of the University of California
LandOfFree
Cell line producing feline leukemia virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell line producing feline leukemia virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell line producing feline leukemia virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-410451